Gut microbes add an average of 600.000 genes to each human being(1) significantly impact s the diversity of disease presentation between males and females through a bidirectional interplay known as the microgenderome. Malignant diseases present diversely between males and females due to the distinct overlapping of biological sex( chromosomes ,hormones) and gender ( sociocultural behaviors, health care access ).In Gestatiunal Trophoblastic Neopplasia ,unique microbial signatures like Prevotella-7 have been proposed as harmless , non invasive diagnostic biomarkers specifically for female only malignant presentations. 1- Epidemiological disparities :Overall ,males have a 14% higher incidence rate a 43% higher mortality rate for most non- reproductive cancers compared to females. Male predominance:Cancer of the bladder ( ≥ 75% male),lung ,esophagus, liver , and kidney (≥60% male ) . Female predominance :Thyroid cancer (75%) gall bladder cancer (65%) Survival :Females generally account for a larger proportion of survivors and have a better 5 year prevalence rates(51.9% vs 48.1 % for males ) 2- Role of biological sex : Biological sex influences cancer through genitex, epigenetics and hormone pathways. SEX CHROMOSOMES ( XX vs XY). X- inactivation escape :Approximately 15-23 % of genes on the inactive x chromosome in females escape silencing. Many of these are tumour suppressor . genes providing females with a double dose of protection. Loss of y (LOY): Complete or extreme down regulation of the y chromosome in ma les is associated with increased burden ,genomic instability and aggressive growth in cancers like bladder and lung. Sex hormones: Estrogen: Often Protective in non reproductive cancers( e.g colorectal ,gastric ,hepatic) by reducing cell proliferation and increasing autophagy.However it promotes growth in thyroid and lung adenocarcinomas. Testosterone:Linked to increased tumour cell proliferation in esophageal ,renal bladder cancers. Immune surveillance : Females typically mount more robust innate and adaptive immune responces, partly due to x- linked immune genes (TLR7) and estrogen immunostimulatory effects. 3-Role of gender (sociocultural factors): 1- Health –Seaking behavior :in developed countries women are more likely to :lumps or melanoma lesions. 2- Diagnostic delay: Men may prioritize work over health visit. Conversely, , in s limits their access to care. 3- Screening Sensitivity:physiological differencies can affect test accuracy can lead to lower sensitivity, for example, slower colon transit times in women (due to progesterone) can lead to lower sensitivity in guaiac –based fecal occult blood test . 4-Treatment response and Toxicity A treatment paradox exist where female soften experience more severe toxicities but have better survival outcomes. Pharmacokinetics :Females generally have higher systemic exposu(re to chemotherapy ( 5-flurouracil ,paxlitaxil) due to lower clearance rates,slower metabolism, and differencies in body composition. Immunotherapy :Males often show better overall survival with immune Sex – specific microbial signature could be used as diagnostic biomarkers for specific malignant diseases. Sex – specific microbial signatures collectively termed Microgenderome are Emerging as powerful non invasive diagnostics and prognostics biomarkers for various malignant diseases.These signatures reflect the complex interplay between sex hormones, immune surveillance,microbial mechanism. 1- Colorectal cancer CRC is one of Colorectal cancer CRC is one of the most extensively studied cancers regarding sex biased microbial markers. Male Specific Signatures:Male patients often show a significant enrichment of specific pathogenic species such as Fusobacterium mortiferum ,Bifidobacterium adolescentis,Succinatimonas hippie. High accuracy diagnostic models have identified Blautia,Bamesiella ,and Anaerostipes as top discrepant bacteria between males and females with CRC. Female Specific Signatures: Female patients are characterized by high levels of Prevotella species,Marseille,Clostredium colinum and Bifidobacterium pseudocatenulatom. Thyroid cancer TC : The prevalence of TC continues to increase world wide (2,3) .female to TC was the second most frequently occurring cancer in people aged 15-44 (4) .While early stage TC is more commonly diagnosed in women with a female to male ratio of approximately 4:1 (6). However ,the reasons behind this sex –based disparity in early stage TC remain unclear (5).Recent studies have identified robiot a microbiota- thyroid axis with distinct sexual dimorphism. Shared vs Unique Markers While both sexes share dominant bacteria like Blautia and Alistipes,there is only a 25% overlap in the dominant bacteria between male and female Diagnostic Models: A highly accurate predictive model( AUC=0.992 )found that is a key distingwishing feature for TC across both sexes. However unique female markers include Shaalia and Moraxilla,while male markers While male markers include Holdimanella and Clostridium senso stricto. 3-Glioma ( Salivary Biomarkers ) Innovative research has pivoted to salivary microbiota as a non invasive diagnostic medium for brain tumours. Sex dependent variations Genera such as Atopopium and Liptotrichia show significant variations in abundance linked to gender in glioma patients. Specific predominanace: Female glioma patients exhit a marked predominanace of Cryptobacterium whereas c-Coriobacteria and o-Coriobacteriales play a more pivotal role in male patients. 4-Pancreatic cancer PDAC Pathogenic Enrichment : Sex specific shifts in the gut and oral microbiome of PDAC patients involve several pathogenic bacteria including Striptococcus, Fusobacterium and Prevotella. Predictive Accuracy :Diagnostic models using these sex- targeted microbial patterns have achieved ACU values exceeding 0.90 for both sexes.